Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Second malignacies complicating Hodgkin's disease. 1 case].

A P Blanc, J A Gastaut, Y Carcassonne

    La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris
    |January 8, 1979
    PubMed
    Summary

    Long-term Hodgkin

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A randomized, double-blind, placebo-controlled study of benfluorex in HIV-infected patients with insulin resistance or impaired glucose tolerance.

    HIV clinical trials·2009
    Same author

    Outcome after reduced-intensity conditioning allogeneic SCT for AML in first complete remission: comparison of two regimens.

    Bone marrow transplantation·2008
    Same author

    Rituximab combined with chemotherapy for lymphoma during pregnancy.

    Leukemia research·2008
    Same author

    A case of rituximab-related urticarial reaction in cutaneous B-cell lymphoma.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2008
    Same author

    JC papovavirus leukoencephalopathy after first line treatment with CHOP and rituximab.

    Haematologica·2007
    Same author

    A phase II trial of rituximab as adjuvant to intensive sequential chemotherapy in patients under 60 years with untreated poor-prognosis diffuse large B-cell lymphoma.

    Bone marrow transplantation·2006

    Area of Science:

    • Oncology
    • Hematology

    Background:

    • Hodgkin's disease (HD) is a lymphoma with varying treatment protocols.
    • Long-term survivors may face secondary malignancies.
    • Radiotherapy and chemotherapy are standard HD treatments.

    Observation:

    • A patient with long-term Hodgkin's disease developed acute myeloblastic leukemia.
    • The patient received multiple cycles of radiotherapy and chemotherapy.

    Findings:

    • Treatment-induced immunosuppression may increase leukemia risk.
    • Viral infections are potential contributors to secondary leukemia.
    • Levamisole and genetic predisposition are also considered factors.

    Implications:

    • Understanding secondary leukemia risks is crucial for long-term cancer survivors.
    • Further research into treatment-related leukemia is warranted.
    • Personalized risk assessment may benefit patients undergoing intensive cancer therapy.

    Related Experiment Videos